Grundinformationen
- Standard-SMILES
O=c1cc[nH]c(=S)[nH]1- InChIKey
ZEMGGZBWXRYJHK-UHFFFAOYSA-N- Summenformel
- C4H4N2OS
- Durchschnittliche Molmasse
- 128,15 g/mol
- Monoisotopische Masse
- 128,00443375
Überblick
Thiouracil can cause cancer according to The World Health Organization's International Agency for Research on Cancer (IARC).
Namen und Bezeichner
- Bevorzugter Name
- Thiouracil
- IUPAC
- 2-sulfanylidene-1H-pyrimidin-4-one
- Lokaler Name
- 2-Thiouracil
- Englischer Name
- 2-Thiouracil
- Summenformel
- C4H4N2OS
- Molmasse
- 128.15
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
141-90-2- PubChem CID
- 1269845
- DTXSID
DTXSID4021347- ChEMBL
CHEMBL345768- ChEBI
CHEBI:348530- UNII
- 59X161SCYL
- EC Number
- 205-508-8
- Nikkaji
- J9.741A
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -0,3
- Polarare Oberfläche (TPSA)
- 73,2 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 8
- Formalladung
- 0
- Komplexität
- 163
Experimentelle und physikochemische Eigenschaften
Color/Form
MINUTE CRYSTALS, PRISMS, OR WHITE OR PALE CREAM-COLORED POWDER
PRISMS FROM WATER OR ALC
Solubility
VERY SLIGHTLY SOL IN WATER (1:2000); PRACTICALLY INSOL IN ETHER, ACIDS; READILY SOL IN ALKALINE SOLN
SLIGHTLY SOL IN ALC; SOL IN ANHYD HYDROGEN FLUORIDE
Collision Cross Section
116.1 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID4021347]
137.08 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
119.87 Ų [M+H]+
Physikochemische Eigenschaften
- Schmelzpunkt
- 300 °C · >300 °C (lit.)
- Dichte
- 1.368 · 1.368 (estimate)
- Brechungsindex
- 1.7 · 1.7000 (estimate)
- storage temp.
- 30 °C · Store below +30°C.
- Löslichkeit
- 7.9 g/l · 7.9g/l
- Aggregatzustand
- Fine Crystalline Powder
- pka
- 7.46 · pKa 7.46 (Uncertain)
- Farbe
- White to cream
- Biologische Quelle
- synthetic
- Wasserlöslichkeit
- 0.5 g/L · 0.5 g/L
- Merck
- 14 · 14,9366
- BRN
- 112227 · 112227
- InChI
- 1S/C4H4N2OS/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)
- InChIKey
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N
- SMILES
- O=C1NC(=S)NC=C1
- CAS Datenbank
- 141 · 141-90-2(CAS DataBase Reference)
- NIST chemische Informationen
- 2 · 2-Thiouracil(141-90-2)
- EPA chemische Informationen
- Thiouracil (141-90-2)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
This chemical does not meet GHS hazard criteria for 5.6% (4 of 71) of reports.
Warning
H351 (94.4%): Suspected of causing cancer [Warning Carcinogenicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 71 reports by companies from 5 notifications to the ECHA C&L Inventory.
Danger
Gefahrenhinweise
Regulatory Information
Chemical: 4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-
Hazard Traits - Carcinogenicity
4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-: Does not have an individual approval but may be used under an appropriate group standard
Hazard Classes and Categories
Carc. 2 (94.4%)
Acute toxicity (Oral) - Category 5
Acute toxicity (Oral) - Category 5
Toxikologische Informationen
Human Toxicity Excerpts
HEMORRHAGE, PETECHIAE, PURPURA.
THIOURACIL CAN INDUCE HEPATIC INJURY. /FROM TABLE/
THESE DRUGS /WHICH INCL THIOURACIL/ HAVE CAUSED NUMEROUS TOXIC SIDE REACTIONS PRINCIPALLY...DRUG FEVER, SKIN ERUPTIONS, & ARTERITIS.
MATERNAL ANTI-THYROID MEDICATION...HAS RESULTED...IN DEVELOPMENT OF FETAL GOITER, & OCCASIONALLY IN HYPOTHYROIDISM IN SOME NEONATE LEADING TO MENTAL RETARDATION. ... JUST OCCASIONALLY, GOITER IN AFFECTED INFANTS MAY OBSTRUCT AIR PASSAGE, & CAUSE RESPIRATORY DISTRESS.
For more Human Toxicity Excerpts (Complete) data for 2-THIOURACIL (6 total), please visit the HSDB record page.
Carcinogen Classification
Thiouracil
Group 2B: Possibly carcinogenic to humans
Volume Sup 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, 1987; 440 pages; ISBN 92-832-1411-0 (out of print)
2001
2000
Non-Human Toxicity Excerpts
DWARFISM & MENTAL RETARDATION...CAN BE PRODUCED IN RATS BY FEEDING DAMS...THIOURACIL...@ DIETARY LEVEL OF 1,000 PPM.
EIGHTY-ONE MICE OF 3 INBRED STRAINS (A, C57 & I) WERE ADMIN 0.1% THIOURACIL (TU) IN COMMERCIAL DIET FOR PERIODS OF UP TO 80 WK. IN 69 MICE EXAM, THYROIDAL FOLLICULAR CYSTS...FOUND & INTERPRETED BY AUTHORS AS NON-MALIGNANT LESIONS, SINCE THEY REGRESSED FOLLOWING WITHDRAWAL OF THIOURACIL...
OF 52 C STRAIN MICE (40 MALES & 12 FEMALES) ADMIN 0.37% THIOURACIL IN DIET FOR 6 MO FOLLOWED BY 0.5% FOR LIFE, LAST ANIMAL DIED @ 116 WK, & NODULAR HYPERPLASIS OF THYROID OCCURRED IN 28/39 MICE SURVIVING LONGER THAN 10 MO... IN (C57XCBA)F1 FEMALE MICE ADMIN 0.2% IN DIET...FROM 1-29 MO, HEPATOMAS...IN 6/21...ANIMALS.
NODULAR HYPERPLASIA OF THYROID WAS OBSERVED IN STANFORD ALBINO RATS OF BOTH SEXES AFTER ADMIN OF 0.1% THIOURACIL IN DIET FOR UP TO 45 WK. INCIDENCE IN MALES INCR FROM 3/10-11/20 AFTER TREATMENT FOR 29 & 45 WK, RESPECTIVELY. NO INCR...IN FEMALE RATS (3/10, COMPARED WITH 5/15) EXAM AFTER TREATMENT FOR 29 & 38 WK...
For more Non-Human Toxicity Excerpts (Complete) data for 2-THIOURACIL (9 total), please visit the HSDB record page.
Evidence for Carcinogenicity
Evaluation: There is inadequate evidence in humans for the carcinogenicity of thiouracil. There is sufficient evidence in experimental animals for the carcinogenicity of thiouracil. Overall evaluation: Thiouracil is probably carcinogenic to humans (Group 2B).
Antidote and Emergency Treatment
EARLIEST SIGN OF HYPOTHYROIDISM CALL FOR REDN IN DOSE; IF BY CHANCE THEY HAVE ADVANCED TO POINT OF DISCOMFORT, THYROID HORMONE CAN BE GIVEN TO HASTEN RECOVERY. FULL DOSE OF 120-180 MG DAILY OF THYROID OR EQUIV OF TYHROXINE OR TRIIODOTHYRONINE FOR WK WILL USUALLY SUFFICE. /ANTI-THYROID DRUGS/
Sicherheitsdaten
- wgk
- 3
- tsca
- TSCA listed
- hs_code
- 29335995
- RTECS-Nr.
- YR1575000
- risk_code
- 40-45-20/21/22
- hazard_code
- Xn,T
- safety_code
- 36/37-53-45
- Speicherklasse
- 11 - Combustible Solids
- Giftige Stoffe Daten
- 141-90-2(Hazardous Substances Data)
- Hazard Classifications
- Carc. 2
- Selbstentzündungstemperatur
- 570°C
Chemie und Industrie
Pharmakologische Informationen
Mechanism of Action
ANTITHYROID DRUGS INHIBIT FORMATION OF THYROID HORMONE LARGELY BY INTERFERING WITH INCORPORATION OF IODINE INTO ORGANIC FORM. THIS IMPLIES THAT THEY INTERFERE WITH OXIDN OF IODIDE ION, BUT ELUCIDATION OF DETAILED MECHANISM... HAMPERED BY INCOMPLETE UNDERSTANDING OF IODIDE-OXIDIZING SYSTEM OF...GLAND. /ANTITHYROID DRUGS/
THIOAMIDE DERIV DO NOT HAVE PERMANENT EFFECT UPON THYROID GLAND BUT INHIBIT HORMONE SYNTHESIS & SECRETION UNTIL SPONTANEOUS REMISSION OCCURS DURING COURSE OF DISEASE. /THIOAMIDE DERIV/
Metabolism/Metabolites
IN HOMOGENIZED RAT LIVER PREPN FROM FEMALE HOLTZMAN RATS, 28-35% OF THIOURACIL WAS METABOLIZED WITHIN 3 HR. PATHWAY FOR BREAKDOWN OF THIOURACIL WAS SUGGESTED TO BE AS FOLLOWS: URACIL; BETA-UREIDOPROPIONIC ACID, WHICH WAS FURTHER METABOLIZED TO BETA-ALANINE; AMMONIA & CARBON DIOXIDE...
MeSH Pharmacological Classification
Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
Drugs used to cause dilation of the blood vessels.
Absorption, Distribution and Excretion
DRUG TRANSMISSION TO FETUS: TIME TO APPEAR IN FETUS 10 MIN; TIME TO FETAL/MATERNAL CONCN EQUILIBRIUM 40 MIN; FETAL/MATERNAL CONCN RATIO 1.0 /FROM TABLE/
/IN RATS/ ACCUMULATION OF (35)S LABEL WAS FASTER & OCCURRED TO GREATER EXTENT FROM SMALLER DOSE, SUGGESTING PRESENCE OF SATURABLE TRANSPORT MECHANISM. SIMILAR STUDIES WITH (14)C-THIOURACIL HAVE SHOWN ACCUM OF RADIOACTIVITY IN BOTH MATERNAL & FETAL THYROID TISSUES OF RABBITS...
...WITH BOTH LARGE (39 UMOL) & SMALL (1.2 UMOL) DOSES OF (35)S-THIOURACIL, CONSIDERABLE ACCUM OF BOTH TOTAL RADIOACTIVITY & UNMETABOLIZED (35)S-THIOURACIL OCCURS IN THYROID TISSUE RELATIVE TO PLASMA /IN RATS/.
THIOURACIL IS ABSORBED FROM GI TRACT IN RATS... IN RATS ADMIN 5 MG BY IV INJECTION, 30% OF THIOURACIL...RECOVERED FROM CARCASSES AFTER 3 HR & ONLY TRACES AFTER 24 HR.
For more Absorption, Distribution and Excretion (Complete) data for 2-THIOURACIL (7 total), please visit the HSDB record page.
Verwendung und Herstellung
Uses
CHEM INT FOR IOTHIOURACIL SODIUM- AN ANTITHYROID AGENT
MEDICATION
MEDICATION (VET)
U.S. Exports
(1972) No Data
(1975) No Data
U.S. Imports
(1972) No Data
(1975) No Data
U.S. Production
(1974) PROBABLY GREATER THAN 4.54X10+5 GRAMS
(1975) PROBABLY GREATER THAN 4.54X10+5 GRAMS
Methods of Manufacturing
CONDENSATION OF ETHYL FORMYLACETATE WITH THIOUREA
PREPD BY CONDENSING ETHYL FORMYLACETATE WITH THIOUREA: WHEELER, LIDDLE, AM CHEM J 40, 550 (1908).
General Manufacturing Information
4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-: ACTIVE
THIOAMIDE DERIV USED IN THIS COUNTRY ARE PROPYLTHIOURACIL, METHIMAZOLE, & METHYLTHIOURACIL. THESE DRUGS HAVE REPLACED PARENT COMPD, THIOURACIL, WHICH IS MORE TOXIC.
Anwendungen
Verwenden2-Thiouracil has been used in the synthesis and characterization of silver colloid and film substrates and their applications in surface-enhanced Raman scattering (SERS)
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter50 Anbieter
Ergänzende Hinweise
DefinitionChEBI: A nucleobase analogue that is uracil in which the oxo group at C-2 is replaced by a thioxo group.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…